The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer

Journal of Breast Cancer

Volumn 14, Issue 3, 2011, Pages 198-203

  Song, Young Ju ^a   Shin, Sun Hyoung ^a   Cho, Jin Seong ^a   Park, Min Ho ^a   Yoon, Jung Han ^a   Jegal, Young Jong ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Breast neoplasms; Lymph node metastasis; Lymphovascular invasion; Prognostic factor

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; BREAST CANCER; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTOR VARIABLE; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW;

EID: 80054728802     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2011.14.3.198     Document Type: Review

References (16)

1. Clark GM. Prognostic and predictive factors. In Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast. 2nd ed Philadelphia: Lippincott Williams & Wilkins; 2000. p.489-514.
2. Woo CS, Silberman H, Nakamura SK, Ye W, Sposto R, Colburn W, et al. Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. Am J Surg 2002; 184:337-40.
3. Davis BW, Gelber R, Goldhirsch A, Hartmann WH, Hollaway L, Russell I, et al. Prognostic signifcance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Hum Pathol 1985;16:1212-8.
4. Page DL, Anderson TJ, Connelly JL, Schnitt SF. Mscellaneous features of carcinoma. In: Page DL, Anderson TJ, editors. Diagnostic Histopa-thology of the Breast. Edinburgh: Churchill Livingstone; 1987. p.283-4.
5. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 1983; 52:1551-7.
6. Rosai J, Sobin LH, editors. Tumors of the Mammary Gland Washington, DC Armed Forces Institute of Pathology; 1993.
7. de Mascarel I, MacGrogan G, Debled M, Sierankowski G, Brouste V, Mathoulin-Pthoulin- S, et al. D2-40 in breast cancer: should we detect more vascular emboli? Mod Pathol 2009;22:216-22.
8. de Mascarel I, Bonichon F, Durand M, Mauriac L, MacGrogan G, Soubeyran I, et al. Obvious peritumoral emboli: an elusive prognostic factor reappraised Multivariate analysis of 1320 node-negative breast cancers. Eur J Cancer 1998;34:58-65.
9. Yildirim E, Berberoglu U. Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients. World J Surg 2007;31:276-89.
10. Colleoni M, Rotmensz N, Maisonneuve P Sonzogni A, Pruneri G, Casa-dio C, et al. Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol 2007; 18:1632-40.
11. MacGrogan G, Desrousseaux M, de Mascarel I. Prognostic value of Mib1 in a tissue microarray of 855 invasive breast carcinomas. 5th European Breast Cancer Conference. 2006;4. Abstract #261.
12. Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA. Te prognostic signifcance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 2005;103:2006-14.
13. Rosen PP. Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical signifcance. Pathol Annu 1983;18 Pt2:215-32.
14. McCready DR, Chapman JA, Hanna WM, Kahn HJ, Murray D, Fish EB, et al. Factors afecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival model. Ann Surg Oncol 2000;7:416-26.
15. Mohammed RA, Martin SG, Gill MS, Green AR, Paish EC, Ellis IO. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am J Surg Pathol 2007; 31:1825-33.
16. Sun Y, Goodison S, Li J, Liu L, Farmerie W. Improved breast cancer prognosis through the combination of clinical and genetic markers. Bioin-formatics 2007;23:30-7.